- Home
- GAIA vs ADAG Comparison
GAIA vs ADAG Comparison
Compare GAIA & ADAG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | GAIA | ADAG |
|---|---|---|
| Founded | 1988 | 2011 |
| Country | United States | China |
| Employees | N/A | N/A |
| Industry | Movies/Entertainment | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 105.7M | 84.8M |
| IPO Year | 1999 | 2021 |
Fundamental Metrics
Financial Performance| Metric | GAIA | ADAG |
|---|---|---|
| Price | $3.72 | $1.85 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 4 |
| Target Price | ★ $9.00 | $8.00 |
| AVG Volume (30 Days) | ★ 133.7K | 61.0K |
| Earning Date | 11-03-2025 | 08-12-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $98,622,000.00 | $103,204.00 |
| Revenue This Year | $11.55 | $6,983.06 |
| Revenue Next Year | $11.08 | $36.05 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 14.80 | N/A |
| 52 Week Low | $2.93 | $1.30 |
| 52 Week High | $6.39 | $3.16 |
Technical Indicators
Market Signals| Indicator | GAIA | ADAG |
|---|---|---|
| Relative Strength Index (RSI) | 42.49 | 49.37 |
| Support Level | $3.39 | $1.76 |
| Resistance Level | $4.05 | $1.93 |
| Average True Range (ATR) | 0.27 | 0.14 |
| MACD | 0.05 | -0.00 |
| Stochastic Oscillator | 43.96 | 53.19 |
Price Performance
Historical ComparisonAbout GAIA Gaia Inc.
Gaia Inc is a video streaming service and community that provides curated conscious media in primary channels; Seeking Truth provides new and enlightening perspectives for today's changing world; Transformation provides a wealth of content in the niche areas of spiritual growth, personal development, and expanded consciousness; Alternative Healing channel features content focused on food and nutrition, holistic healing, alternative and integrative medicines, and longevity, and Yoga. Geographically, it derives a majority of its revenue from the United States and also has an International presence.
About ADAG Adagene Inc.
Adagene Inc is a platform-driven, clinical-stage biopharmaceutical company engaged in transforming the discovery and development of novel antibody-based cancer immunotherapies. It is principally engaged in research, development, and production of monoclonal antibody drugs for cancers. The company's platform is designed to generate therapeutic antibody candidates with functional epitopes and species cross-reactivity, as highlighted by the company's immunotherapy pipeline.